Biome Australia Ltd (BIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biome Australia Ltd (BIO) has a cash flow conversion efficiency ratio of 0.344x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$2.09 Million ≈ $1.48 Million USD) by net assets (AU$6.06 Million ≈ $4.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Biome Australia Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Biome Australia Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Biome Australia Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biome Australia Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CHUNGDAHM Learning Inc
KQ:096240
|
-0.110x |
|
T&R Biofab Co. Ltd
KQ:246710
|
0.002x |
|
Demisas Dokum Emaye Mamulleri Sanayi AS
IS:DMSAS
|
-0.026x |
|
Elastron S.A. - Steel Service Centers
AT:ELSTR
|
-0.043x |
|
GenoFocus Inc
KQ:187420
|
-0.015x |
|
Information and Communication Networks Public Company Limited
BK:ICN
|
0.114x |
|
Econpile Holdings Bhd
KLSE:5253
|
0.006x |
|
Granprade
JSE:GPL
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Biome Australia Ltd (2019–2025)
The table below shows the annual cash flow conversion efficiency of Biome Australia Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Biome Australia Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$4.68 Million ≈ $3.31 Million |
AU$-2.82 Million ≈ $-2.00 Million |
-0.603x | -969.00% |
| 2024-06-30 | AU$2.90 Million ≈ $2.05 Million |
AU$-163.81K ≈ $-115.90K |
-0.056x | +94.21% |
| 2023-06-30 | AU$3.59 Million ≈ $2.54 Million |
AU$-3.50 Million ≈ $-2.47 Million |
-0.975x | -85.99% |
| 2022-06-30 | AU$6.53 Million ≈ $4.62 Million |
AU$-3.42 Million ≈ $-2.42 Million |
-0.524x | -122.82% |
| 2021-06-30 | AU$10.17 Million ≈ $7.20 Million |
AU$-2.39 Million ≈ $-1.69 Million |
-0.235x | +93.06% |
| 2020-06-30 | AU$949.54K ≈ $671.86K |
AU$-3.22 Million ≈ $-2.28 Million |
-3.392x | -91.64% |
| 2019-06-30 | AU$1.20 Million ≈ $852.36K |
AU$-2.13 Million ≈ $-1.51 Million |
-1.770x | -- |
About Biome Australia Ltd
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through … Read more